Evaluation of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Circulation: Cardiovascular Interventions
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent
Circ Cardiovasc Interv 2021 Mar 01;[EPub Ahead of Print], AJ Kirtane, R Stoler, R Feldman, FJ Neumann, L Boutis, N Tahirkheli, R Toelg, I Othman, B Stein, JW Choi, S Windecker, RW Yeh, HL Dauerman, MJ Price, P Underwood, D Allocco, I Meredith, DJ KereiakesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.